Current prophylactic HPV vaccines and gynecologic premalignancies.

Current opinion in obstetrics & gynecology

Volumn 21, Issue 6, 2009, Pages 457-464

  Harper, Diane M ^a  

^a TRUMAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18; HUMAN PAPILLOMAVIRUS VACCINE, L1 TYPE 16, 18; WART VIRUS VACCINE;

CLINICAL TRIAL; CROSS PROTECTION; FEMALE; HUMAN; IMMUNOLOGY; PAPILLOMA VIRUS; PATHOGENICITY; PATHOLOGY; REVIEW; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIALS AS TOPIC; CROSS PROTECTION; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77950479507     PISSN: None     EISSN: 1473656X     Source Type: Journal    
DOI: None     Document Type: Review

References (91)